On the other hand, nondopaminergic drugs include serotoninergics, alpha 2‐adrenergic antagonists, and adenosine A2a antagonists which may benefit in relapse or progression stage of PD for motor symptoms and motor complications (Elkouzi et al., 2019). This evidence concerns the gene PSMA2 and Parkinson disease.